The Chromatography Forum

of Delaware Valley

Daniel Steyer is an Investigator for Drug Substance and Product Analysis at GSK. His main focus is supporting biopharmaceutical R&D through the development and application of methods for measuring drug formulation components and process-related impurities. Daniel received his PhD at the University of Michigan, where he designed approaches for pairing droplet microfluidics and mass spectrometry. Prior to starting at GSK, Daniel performed postdoctoral work at Florida State University, where he designed microfluidic systems for studying pancreatic islet secretion patterns.